Cocrystal Pharma, Inc. 8K

Cocrystal Pharma appointed Carol Brosgart, MD to its Board of Directors effective August 12, 2026.

Cocrystal Pharma, Inc. announced that it has appointed Carol Brosgart, MD, a veteran in antiviral therapy and biopharma advisory, to its Board of Directors effective August 12, 2026, adding extensive clinical, regulatory, and industry experience to support the advancement of its antiviral pipeline, including lead candidate CDI-988 for norovirus.

Filing Facts

CIK

1412486

Ticker

-

Form

8K

Source Type

sec

Accession

0001493152-26-038747

Alert Tier

5